189 related articles for article (PubMed ID: 8565786)
1. Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone.
Mutlib AE; Strupczewski JT; Chesson SM
Drug Metab Dispos; 1995 Sep; 23(9):951-64. PubMed ID: 8565786
[TBL] [Abstract][Full Text] [Related]
2. Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone.
Mutlib AE; Klein JT
J Pharmacol Exp Ther; 1998 Sep; 286(3):1285-93. PubMed ID: 9732390
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
Mutlib AE; Jurcak J; Hrib N
Drug Metab Dispos; 1996 Oct; 24(10):1139-50. PubMed ID: 8894517
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
Szewczak MR; Corbett R; Rush DK; Wilmot CA; Conway PG; Strupczewski JT; Cornfeldt M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1404-13. PubMed ID: 7562515
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
Szczepanik AM; Brougham LR; Roehr JE; Conway PG; Ellis DB; Wilmot CA
J Pharmacol Exp Ther; 1996 Aug; 278(2):913-20. PubMed ID: 8768747
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
[TBL] [Abstract][Full Text] [Related]
7. The metabolism and excretion of risperidone after oral administration in rats and dogs.
Meuldermans W; Hendrickx J; Mannens G; Lavrijsen K; Janssen C; Bracke J; Le Jeune L; Lauwers W; Heykants J
Drug Metab Dispos; 1994; 22(1):129-38. PubMed ID: 7512019
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the novel benzisothiazole ring-cleaved products of the antipsychotic drug ziprasidone.
Prakash C; Kamel A; Cui D
Drug Metab Dispos; 1997 Jul; 25(7):897-901. PubMed ID: 9224786
[TBL] [Abstract][Full Text] [Related]
9. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
[TBL] [Abstract][Full Text] [Related]
10. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
[TBL] [Abstract][Full Text] [Related]
11. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics. 2. Pharmacological profile of 7-[3-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)-piperidin-1-yl]propoxy]-3-(hydroxymeth yl)chromen -4-one (abaperidone, FI-8602).
Bolós J; Anglada L; Gubert S; Planas JM; Agut J; Príncep M; De la Fuente N; Sacristán A; Ortiz JA
J Med Chem; 1998 Dec; 41(27):5402-9. PubMed ID: 9876110
[TBL] [Abstract][Full Text] [Related]
12. Picogram determination of iloperidone in human plasma by solid-phase extraction and by high-performance liquid chromatography-selected-ion monitoring electrospray mass spectrometry.
Mutlib AE; Strupczewski JT
J Chromatogr B Biomed Appl; 1995 Jul; 669(2):237-46. PubMed ID: 7581900
[TBL] [Abstract][Full Text] [Related]
13. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
14. Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS.
Duarte IF; Legido-Quigley C; Parker DA; Swann JR; Spraul M; Braumann U; Gil AM; Holmes E; Nicholson JK; Murphy GM; Vilca-Melendez H; Heaton N; Lindon JC
Mol Biosyst; 2009 Feb; 5(2):180-90. PubMed ID: 19156264
[TBL] [Abstract][Full Text] [Related]
15. Identification of rat urinary metabolites of rifabutin using LC-MSn and LC-HR-MS.
Prasad B; Singh S
Eur J Pharm Sci; 2010 Sep; 41(1):173-88. PubMed ID: 20558285
[TBL] [Abstract][Full Text] [Related]
16. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
[TBL] [Abstract][Full Text] [Related]
17. Preclinical characterization of 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]benzoic acid metabolism: in vitro species comparison and in vivo disposition in rats.
Perkins EJ; Cramer JW; Farid NA; Gadberry MG; Jackson DA; Mattiuz EL; O'Bannon DD; Weiss HJ; Wheeler WJ; Wood PG; Cassidy KC
Drug Metab Dispos; 2003 Nov; 31(11):1382-90. PubMed ID: 14570771
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
Schuster P; Bertermann R; Snow TA; Han X; Rusch GM; Jepson GW; Dekant W
Toxicol Appl Pharmacol; 2008 Dec; 233(2):323-32. PubMed ID: 18817801
[TBL] [Abstract][Full Text] [Related]
19. Characterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS.
Mutlib AE; Chui YC; Young LM; Abbott FS
Drug Metab Dispos; 1992; 20(6):840-8. PubMed ID: 1362936
[TBL] [Abstract][Full Text] [Related]
20. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
Bu HZ; Poglod M; Micetich RG; Khan JK
J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]